West Pharmaceutical Services Statistics
Share Statistics
West Pharmaceutical Services has 72.42M shares outstanding. The number of shares has increased by -1.07% in one year.
| Shares Outstanding | 72.42M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.16% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 71.99M |
| Failed to Deliver (FTD) Shares | 94 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 1.16M, so 1.6% of the outstanding shares have been sold short.
| Short Interest | 1.16M |
| Short % of Shares Out | 1.6% |
| Short % of Float | 1.61% |
| Short Ratio (days to cover) | 2.36 |
Valuation Ratios
The PE ratio is 44.09 and the forward PE ratio is 44.83. West Pharmaceutical Services 's PEG ratio is 3.15.
| PE Ratio | 44.09 |
| Forward PE | 44.83 |
| PS Ratio | 8.87 |
| Forward PS | 7.2 |
| PB Ratio | 9.08 |
| P/FCF Ratio | 63.12 |
| PEG Ratio | 3.15 |
Enterprise Valuation
West Pharmaceutical Services Inc. has an Enterprise Value (EV) of 25.62B.
| EV / Earnings | 43.17 |
| EV / Sales | 8.68 |
| EV / EBITDA | 30.35 |
| EV / EBIT | 37.9 |
| EV / FCF | 61.8 |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.88 |
| Quick Ratio | 2.24 |
| Debt / Equity | 0.11 |
| Total Debt / Capitalization | 9.69 |
| Cash Flow / Debt | 2.51 |
| Interest Coverage | 75.11 |
Financial Efficiency
Return on equity (ROE) is 0.21% and return on capital (ROIC) is 17.48%.
| Return on Equity (ROE) | 0.21% |
| Return on Assets (ROA) | 0.15% |
| Return on Capital (ROIC) | 17.48% |
| Revenue Per Employee | 278.28K |
| Profits Per Employee | 55.98K |
| Employee Count | 10.60K |
| Asset Turnover | 0.77 |
| Inventory Turnover | 4.19 |
Taxes
| Income Tax | 122.30M |
| Effective Tax Rate | 0.18 |
Stock Price Statistics
The stock price has increased by -5.2% in the last 52 weeks. The beta is 1, so West Pharmaceutical Services 's price volatility has been higher than the market average.
| Beta | 1 |
| 52-Week Price Change | -5.2% |
| 50-Day Moving Average | 325.36 |
| 200-Day Moving Average | 325.34 |
| Relative Strength Index (RSI) | 49.78 |
| Average Volume (20 Days) | 612.88K |
Income Statement
In the last 12 months, West Pharmaceutical Services had revenue of 2.95B and earned 593.40M in profits. Earnings per share was 7.99.
| Revenue | 2.95B |
| Gross Profit | 1.13B |
| Operating Income | 676.00M |
| Net Income | 593.40M |
| EBITDA | 844.10M |
| EBIT | 676.00M |
| Earnings Per Share (EPS) | 7.99 |
Balance Sheet
The company has 853.90M in cash and 309.00M in debt, giving a net cash position of 544.90M.
| Cash & Cash Equivalents | 853.90M |
| Total Debt | 309.00M |
| Net Cash | 544.90M |
| Retained Earnings | 3.52B |
| Total Assets | 3.68B |
| Working Capital | 1.03B |
Cash Flow
In the last 12 months, operating cash flow was 776.50M and capital expenditures -362.00M, giving a free cash flow of 414.50M.
| Operating Cash Flow | 776.50M |
| Capital Expenditures | -362.00M |
| Free Cash Flow | 414.50M |
| FCF Per Share | 5.58 |
Margins
Gross margin is 38.28%, with operating and profit margins of 22.92% and 20.12%.
| Gross Margin | 38.28% |
| Operating Margin | 22.92% |
| Pretax Margin | 23.66% |
| Profit Margin | 20.12% |
| EBITDA Margin | 28.62% |
| EBIT Margin | 22.92% |
| FCF Margin | 14.05% |
Dividends & Yields
WST pays an annual dividend of $0.84, which amounts to a dividend yield of 0.25%.
| Dividend Per Share | $0.84 |
| Dividend Yield | 0.25% |
| Dividend Growth (YoY) | 5% |
| Payout Ratio | 12.48% |
| Earnings Yield | 2.43% |
| FCF Yield | 1.74% |
Analyst Forecast
The average price target for WST is $400, which is 21.8% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $400 |
| Price Target Difference | 21.8% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
Stock Splits
The last stock split was on Sep 27, 2013. It was a forward split with a ratio of 2:1.
| Last Split Date | Sep 27, 2013 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 18.79 |
| Piotroski F-Score | 5 |